Company Name : October Pharma
ISIN Code : EGS380R1C018
Reuters Code : OCPH.CA
Content :
EGX decided to resume trading on the company effective 25/02/2019 trading session at 11:35 AM, as the company sent its Board of Directors' decisions held on 24/02/2019 concerning the unaudited financial results for the year ended 31/12/2018.
News Attachment I (458 KB)
News Attachment II (851 KB)
News Attachment III (72 KB)